| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| closedAccess |  | 2008 | A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: In vitro and in vivo study | Martins, Ana Sofia; Ordóñez, José Luis CSIC ORCID CVN; García-Sánchez, Alfredo; Herrero-Martín, David; Sevillano, Victoria CSIC; Osuna, Daniel CSIC ORCID; Mackintosh, Carlos CSIC ORCID; Caballero, Gemma; Otero, Ana P.; Madoz-Gúrpide, Juan CSIC ORCID; Álava, Enrique de CSIC ORCID | artículo |
| closedAccess |  | 2009 | Advances in Ewing's sarcoma research: Where are we now and what lies ahead? | Ordóñez, José Luis CSIC ORCID CVN; Osuna, Daniel CSIC ORCID; Herrero-Martín, David; Álava, Enrique de CSIC ORCID; Madoz-Gúrpide, Juan CSIC ORCID | artículo |
| openAccess |  | 2005 | Imatinib is not a potential alternative treatment for uterine leiomyosarcoma (multiple letters) | Mackintosh, Carlos CSIC ORCID; Herrero-Martín, David; Martins, Ana Sofia; Abad, María del Mar; Álava, Enrique de CSIC ORCID; Hernández, Mª Teresa; Orfao, Alberto CSIC ORCID | artículo |
| closedAccess |  | 2006 | Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor | Martins, Ana Sofia; Mackintosh, Carlos CSIC ORCID; Herrero-Martín, David; Campos, M.; Hernández, Mª Teresa; Ordóñez, José Luis CSIC ORCID CVN; Álava, Enrique de CSIC ORCID | artículo |
| closedAccess |  | 1-abr-2020 | LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity | Almacellas-Rabaiget, Olga; Monaco, Paola; Huertas-Martinez, Juan; García-Monclús, Silvia; Chicón-Bosch, Mariona; Maqueda-Marcos, Susana; Fabra-Heredia, Isabel; Herrero-Martín, David; Rello-Varona, Santiago; Álava, Enrique de CSIC ORCID; López-Alemany, Roser; Giangrande, Paloma H.; Tirado, Óscar M. | artículo |
| closedAccess |  | 2008 | Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy | Schaefer, Karl-Ludwig; Herrero-Martín, David | artículo |
| openAccess |  | 2009 | Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target | Herrero-Martín, David; Álava, Enrique de CSIC ORCID | artículo |
| openAccess |  | 2012 | The first European interdisciplinary Ewing sarcoma research summit | Kovar, Heinrich; Alonso, Javier; Álava, Enrique de CSIC ORCID; Herrero-Martín, David | artículo |
| openAccess |  | 9-may-2010 | The molecular pathogenesis of Ewing sarcoma | Mackintosh, Carlos CSIC ORCID; Madoz-Gúrpide, Juan CSIC ORCID; Ordóñez, José Luis CSIC ORCID CVN; Osuna, Daniel CSIC ORCID; Herrero-Martín, David | artículo |
| openAccess |  | 2015 | The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin | Ordóñez, José Luis CSIC ORCID CVN; Amaral, Ana Teresa CSIC; Herrero-Martín, David; García-Macías, Carmen CSIC ORCID CVN; Sevillano, Victoria CSIC; San-Segundo, Laura CSIC; Fraile, Susana CSIC; Teodosio, Cristina; Tirado, Óscar M.; Mora, Jaume; Álava, Enrique de CSIC ORCID | artículo |
